MOMENT registry: Patients with advanced non-small-cell lung cancer harboring MET exon 14 skipping treated with systemic therapy.

MLA

Thomas, Michael, et al. “MOMENT Registry: Patients with Advanced Non-Small-Cell Lung Cancer Harboring MET Exon 14 Skipping Treated with Systemic Therapy.” Journal of Comparative Effectiveness Research, vol. 14, no. 2, Feb. 2025, p. e240127. EBSCOhost, https://doi.org/10.57264/cer-2024-0127.

APA

Thomas, M., Christopoulos, P., Iams, W. T., Mazières, J., Cortot, A. B., Peled, N., Minuti, G., Smit, E. F., Audhuy, F., Berghoff, K., Eggleton, S. P., Fries, F., Hildenbrand, M., Liu, P., Mahmoudpour, S. H., Menzel, C., & Oksen, D. (2025). MOMENT registry: Patients with advanced non-small-cell lung cancer harboring MET exon 14 skipping treated with systemic therapy. Journal of Comparative Effectiveness Research, 14(2), e240127. https://doi.org/10.57264/cer-2024-0127

Chicago

Thomas, Michael, Petros Christopoulos, Wade T Iams, Julien Mazières, Alexis B Cortot, Nir Peled, Gabriele Minuti, et al. 2025. “MOMENT Registry: Patients with Advanced Non-Small-Cell Lung Cancer Harboring MET Exon 14 Skipping Treated with Systemic Therapy.” Journal of Comparative Effectiveness Research 14 (2): e240127. doi:10.57264/cer-2024-0127.